University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 2N-19-2


A Phase 3, Randomized, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK-3475) in Participants with Medically Inoperable Stages I or IIA Non Small Cell Lung Cancer (NSCLC) (KEYNOTE-867)

Type: Treatment
Phase: Phase III
Status: Open to Accrual
Treatments: Immunotherapy, Radiation: External
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Jason Ye, M.D.
Other Trial Staff:  Victoria Amran, D.M., Grace Facio, Coordinator, Mary Ordaz, D.M., Gina Tse, Coordinator, Eduardo Mejia, D.M., America Casillas-Lopez, Coordinator, Laurie De Oliveira, Coordinator, Niranjan Bhatt, D.M., Alix Cohen, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.